FUTURE: Much of the meeting was devoted to the things the government would be doing in the near future: expect Precision Medicine Initiative announcements in the next couple weeks, advised NIHs Kathy Hudson; healthit.gov/transparency, which will provide more information regarding whats for sale to
Date: Jun 01, 2016
Category: Health
Source: Google
NIH appoints a team of experts that will ensure patients' safety
Were going to work with the facilities to get them in compliance, said Kathy Hudson, an NIH deputy director who helps oversee the drug-study issue at the agency. The entirety of NIH is working shoulder-to-shoulder to make this happen as soon as we can.
21st Century Cures Act is the subject of a hearing today by the health subcommittee of the House Energy & Commerce Committee. Scheduled to give testimony are Kathy Hudson, Ph.D., NIHs deputy director for science, outreach, and policy; and two FDA officials: Janet Woodcock, M.D., director of the
ational Institutes of Health caught this and that these poor results are simply unacceptable. That person is the National Institutes of Health deputy director of Science Outreach and Policy, Kathy Hudson, PhD says, The poor results reporting of NIH-funded clinical trials to ClinicTrials.gov descri
Date: Mar 12, 2015
Category: Health
Source: Google
Clinical Trial Results Hardly Ever Timely Disclosed, Study
In the light of the study, Kathy Hudson, deputy director of science, outreach and policy for the NIH gave a statement, rendering the results regarding the NIH-funded clinical trials simply unacceptable.
Date: Mar 12, 2015
Category: Health
Source: Google
Trial Results Seldom Posted to Clinicaltrials.gov as Required
The poor results reporting of NIH-funded clinical trials to ClinicalTrials.gov described in the new study is simply unacceptable, Kathy Hudson, PhD, NIH Deputy Director of Science Outreach and Policy, said in an email to MedPage Today. The study confirms the need for the NIHs newly proposed poli
Date: Mar 11, 2015
Source: Google
National Institutes Of Health Manager Supports Precision Medicine Program
Dr. Collins has selected Kathy Hudson, Deputy Director of NIH and Dr. Richard Lifton, a geneticist, to head a panel that will work toward handling patient data. Dr. Collins suggests that the new panel will evaluate numerous proposals in the coming months and will have an estimation to begin the prog
Date: Mar 08, 2015
Category: Health
Source: Google
Proposed rules will vastly expand trove of clinical trial data reported in US ...
within 21 days of enrolling the first patient, for example. This will make it easier to enforce compliance with the rules, for example by withholding funding for NIH grantees or imposing fines on companies regulated by FDA, said Kathy Hudson, NIHs deputy director for science, outreach, and policy. T